Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Novel targeted aptamer-superparamagnetic iron oxide nanoparticles bioconjugates for combined prostate cancer imaging and therapy

Novel targeted aptamer-superparamagnetic iron oxide nanoparticles bioconjugates for combined prostate cancer imaging and therapy. International Journal of Radiation Oncology*Biology*Physics. 2007; 69(3):S110-1.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.